IMMUCELL CORP /DE/ Balance Sheet
ICCC|10 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$43M
FY2025
Cash
$4M
Cash and equivalents
Total Debt
$7M
FY2025
Shareholder Equity
$28M
FY2025
IMMUCELL CORP /DE/ had $43M in total assets and $28M in shareholders' equity as of FY2025. Total debt was $7M against $4M in cash, resulting in $4M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Conservative debt: Debt-to-equity ratio of 0.27
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.8M | - | $978.7K | $5.2M | $1.6M | $850.0K | $2.7M | $781.5K | $1.4M | $975.5K |
| Accounts Receivable | $3.4M | $3.8M | $2.2M | $1.3M | $992.4K | $754.1K | $1.0M | $631.4K | $574.1K | $346.4K |
| Inventory | $9.3M | $7.1M | $7.8M | $2.0M | $2.1M | $870.2K | $945.8K | $1.2M | $1.6M | $1.7M |
| Current Assets | $16.9M | $15.0M | - | $7.5M | $14.3M | $7.9M | $5.5M | $7.3M | $7.4M | $7.2M |
| PP&E (Net) | $21.1M | $25.3M | $27.6M | $26.1M | $9.8M | $5.7M | $3.8M | $2.5M | $2.4M | $2.5M |
| Goodwill | $95.6K | $95.6K | $95.6K | $95.6K | $95.6K | - | - | - | - | - |
| Total Assets | $42.5M | $43.8M | $44.9M | $34.3M | $24.7M | $14.6M | $11.1M | $11.0M | $11.0M | $11.0M |
| Current Liabilities | $4.0M | $4.4M | $4.2M | $2.1M | $2.1M | $817.6K | $1.0M | $635.6K | $665.8K | $635.0K |
| Total Debt | $7.5M | - | - | - | - | - | - | $929.2K | $1.2M | - |
| Shareholders' Equity | $27.5M | $25.0M | $30.4M | $19.7M | $10.6M | $9.3M | $9.2M | $9.0M | $9.3M | $9.6M |